financetom
Business
financetom
/
Business
/
PRESS DIGEST-Canada - September 9
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
PRESS DIGEST-Canada - September 9
Sep 9, 2025 5:46 AM

Sept 9 (Reuters) - The following are the top stories

from selected Canadian newspapers. Reuters has not verified

these stories and does not vouch for their accuracy.

THE GLOBE AND MAIL

** Vancouver's Teck Resources ( TECK ) and London's Anglo

American are to come together in a merger that will

create the worlds' fourth-biggest copper producer as the hunt

for critical metals intensifies.

** Swedish telecom equipment maker Ericsson has

laid off a group of Canada-based technical employees, citing a

need to streamline costs and a broader strategy to consolidate

its global work force.

** Global logistics giant DP World has been tapped to build

and run the Port of Montreal's new Contrecoeur container

terminal, expanding its Canadian operations as the federal

government seeks to counter U.S. trade protectionism with new

infrastructure investments.

(Compiled by Bengaluru newsroom)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Protagonist Therapeutics, Takeda's Potential Polycythemia Vera Drug Meets Primary Endpoint
Protagonist Therapeutics, Takeda's Potential Polycythemia Vera Drug Meets Primary Endpoint
Jun 2, 2025
04:02 AM EDT, 06/02/2025 (MT Newswires) -- Protagonist Therapeutics ( PTGX ) and Takeda (TAK) said Sunday their investigational drug rusfertide as a potential treatment for patients with polycythemia vera met primary and key secondary endpoints in a randomized, placebo-controlled phase 3 study. The companies, which are co-developing the drug, said 76.9% of patients in the 156-week, 293-patient study receiving...
Sanofi to Acquire Blueprint Medicines for Up to $9.5 Billion
Sanofi to Acquire Blueprint Medicines for Up to $9.5 Billion
Jun 2, 2025
03:46 AM EDT, 06/02/2025 (MT Newswires) -- Sanofi ( SNY ) has agreed to acquire Blueprint Medicines ( BPMC ) in a deal worth up to $9.5 billion, the companies said Monday. Under the deal, Sanofi ( SNY ) will launch a tender offer to acquire all outstanding shares of Blueprint for $129 each in cash, plus a contingent value...
AstraZeneca Says Camizestrant Combo Shows Benefit in Advanced Breast Cancer Phase 3 Trial
AstraZeneca Says Camizestrant Combo Shows Benefit in Advanced Breast Cancer Phase 3 Trial
Jun 2, 2025
04:08 AM EDT, 06/02/2025 (MT Newswires) -- AstraZeneca ( AZN ) said Sunday a phase 3 study of its camizestrant drug combined with another cancer medicine demonstrated a significant and meaningful improvement in progression-free survival in patients with a type of difficult-to-treat breast cancer. The company said its combination therapy reduced the risk of disease progression or death by 56%...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved